Skip to main content
. 2012 Nov 14;12:127. doi: 10.1186/1471-2393-12-127

Table 3.

Side-effects: % (n)*

 
Misoprostol
Surgical
p-value
  n = 465 n = 374  
Severity of side effects
 
 
 
 “None”
14.8 (65/440)
24.0 (53/221)
0.02
 “Easily tolerable” / “tolerable”
77.5 (341/440)
71.0 (157/221)
 “Severe” / “very severe”
7.7 (34/440)
5.0 (11/221)
Normal bleeding**
35.4 (119/336)
9.4 (17/180)
< 0.001
Heavy bleeding**
11.6 (39/336)
0.6 (1/180)
< 0.001
Spotting***
31.0 (104/336)
51.1 (92/180)
< 0.001
Pain/cramps**
54.8 (184/336)
24.4 (44/180)
< 0.001
Fever/chills**
3.9 (13/336)
1.7 (3/180)
0.20
Nausea**
16.7 (56/336)
2.8 (5/180)
< 0.001
Vomiting**
7.1 (24/336)
1.1 (2/180)
< 0.01
Headache
7.7 (26/336)
8.9 (16/180)
0.74
Gastrointestinal issues
15.2 (51/336)
3.9 (7/180)
< 0.001
Vertigo
1.2 (4/336)
4.4 (8/180)
0.03
Tolerability of pain**
 
 
 
 “No pain”
5.1 (17/332)
5.6 (10/177)
< 0.01
 “Very tolerable” / “tolerable”
92.2 (306/332)
85.3 (151/177)
 “Not tolerable”
2.7 (9/332)
9.0 (16/177)
Difficulty of treatment***
 
 
0.45
 “Not at all difficult” / “a little difficult”
95.4 (290/304)
97.4 (148/152)
 “Difficult” / “very difficult”
4.6 (14/304)
2.6 (4/152)
Acceptability of bleeding**
 
 
 
 “Acceptable” / “very acceptable”
99.1 (328/331)
100.0 (174/174)
0.56
 “Not acceptable” 0.9 (3/331) 0.0 (0/0)  

*Denominators vary due to response rate for each question.

**Data only collected in Senegal, Nigeria, and Burkina Faso.

***Data only collected in Senegal and Burkina Faso.

Listed in “other” side effects; only collected in Senegal, Nigeria, and Burkina Faso.